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A B S T R A C T
Introduction. Diabetes mellitus (DM) is a multiorgan disease that leads to neurovascular complications that disturb
the normal erectile function.
Aim. The aim of the current work was to study the early changes occurring in the level of calcitonin gene-related
peptide (CGRP) and histopathological changes in penile tissues of uncontrolled diabetic rats.
Materials andMethods. This study was carried on 50 adult male Sprague-Dawley rats divided into two main groups:
group I (control, n = 10) and group II (diabetic, n = 40). Type I DM was induced by a single intraperitoneal injection
of streptozotocin (60 mg/kg). The tissue level of CGRP and histopathological examination of rat penises were
assessed at 2, 4, 6, and 8 weeks after induction of DM.
Results. CGRP was higher in the diabetic group at 4, 6, and 8 weeks than in the control group. However, endothelial
changes and decreased smooth muscles mass started only 2 weeks after induction of DM.
Conclusion. Deterioration of histopathological features of the uncontrolled diabetic rats corporeal tissues is time
dependent. Furthermore, vascular changes seem to precede the neurological changes. El-Kamshoushi AAM,
AbdallahWI, Helal SF, El Azhary NM, and Hassan EM. A study of the early changes of the level of calcitonin
gene-related peptide and histopathology of penises of rats with experimentally induced type I diabetes
mellitus by streptozocin. Sex Med 2013;1:21–29.
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Introduction
Penile erection is a complex neurovascularevent modulated by psychological, hormonal
factors and some cellular components such as
endothelial cells and biochemical factors [1].
Erectile dysfunction (ED) has a long list of
causes especially in patients who have neurological
or vascular problems. So, its prevalence is higher
among diabetic men, even at a younger age com-
pared with men without diabetes [2].
Pathophysiology of diabetic ED ismultifactorial
due to occurrence of neural, vascular, endocrinal,
metabolic, and psychogenic changes [3]. This study
focused on the vascular and neural aspects of the
diabetic ED, trying to discover which precedes the
other.
Diabetic neuropathy initially affects small
unmyelinated ﬁbers and later, larger myelinated
ﬁbers. The putative pathogenesis of diabetic neu-
ropathy includes the accumulation of sorbitol and
fructose, auto-oxidation of glucose leading to the
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formation of reactive oxygen species, advanced
glycation end-products produced by nonen-
zymatic glycation of proteins, inappropriate
activation of protein kinase C and a deﬁcit of
neurotrophic supports [4].
Several neurotrophins as neurotrophin 3
(NT-3), NT-4, and nerve growth factor (NGF) are
known to have a positive effect on the nerve dys-
function in diabetic cavernous tissue [5]. The latter
is even suggested to mediate the action of CGRP
[6].
Calcitonin gene-related peptide (CGRP) is an
important neuropeptide involved in penile erec-
tion [7]. It is present in the central and peripheral
nervous system, mainly in close approximation
with blood vessels [8] while in the periphery, it is
located in small, unmyelinated sensory C ﬁbers
and myelinated type A ﬁbers [9]. CGRP is a potent
arterial and venous vasodilator that acts directly on
the smooth muscles to stimulate adenylate cyclase
enzyme. The resulting rise in cyclic adenosine
monophosphate (cAMP) activates protein kinase
A, which cause opening of potassium channels,
leading to muscular relaxation [10].
On the other hand, various pathological
changes affect the endothelial cells and smooth
muscle of corpus cavernosum in diabetic patients.
They lead to endothelial dysfunction, increased
the contractile susceptibility of the smooth
muscles with decreased response to the relaxation
factors and ﬁnally ﬁbrosis and atrophy of the
corpus cavernosum [11].
The purpose of the current study was to detect
the early pathological changes that take place in
diabetic rats’ corpus cavernosum. In addition,
measurement of the level of CGRP in corpus
cavernosum was done along 8 weeks to evaluate
the effect of diabetes on these components; hoping
to solve the debate about which is primary
affected: endothelial or neurological component of
diabetic erectile tissues.
We hypothesized that the diabetic state would
be associated with progressive loss of endothelial
integrity in the corporal spaces of the penis. Fur-
thermore, we hypothesized that there would be
upregulation of CGRP in diabetic rats consistent
with reports by other investigators.
Material and Methods
Animal Model Selection
After approval of the experimental protocol by the
Ethics Committee of the Faculty of Medicine,
Alexandria University, this study was carried on
50 adult male Sprague-Dawley rats, weighing
150–200 g. They were supplied by the lab of
the Physiology Department, Faculty of Medicine,
Alexandria University. Rats were housed at room
temperature, in polypropylene cages, with free
access to standard diet and tap water. They were
randomly distributed into two main groups:
• Group I (control group): 10 normal rats that
received a single intraperitoneal injection of
saline (similar volume to the injected amount of
streptozocin in group II).
• Group II: 40 rats that received a single intra-
peritoneal injection of streptozotocin (STZ) in a
dose of 60 mg/kg body weight, to induce type I
diabetes mellitus (DM) [12]. STZwas purchased
from Sigma (St. Louis, MO,USA) and diluted in
citrate buffer (0.01 M, pH 4.6).
Diabetic Status
Induction of diabetes was veriﬁed 48 hours after
STZ injection. Rats with fasting blood glucose
(FBG) levels higher than 300 mg/dL were consid-
ered to be diabetic [13]. Group II diabetic rats
were further subdivided into four subgroups (IIa,
IIb, IIc, and IId), each containing 10 rats and sac-
riﬁced 2, 4, 6, and 8 weeks after induction of DM,
respectively. No hypoglycemic drugs were given to
diabetic rats during the experiment.
Preparation of Samples
At the end of experimental period, after an over-
night fasting, experimental manipulations were
carried out with the animals under light ether
anesthesia and under complete sterile conditions.
The following parameters were measured at
2 weeks after saline or STZ injection in group I
and IIa, respectively, as well as in group IIb at
4 weeks, in group IIc at 6 weeks and ﬁnally in
group IId at 8 weeks:
1. FBG level (by tail tip prick with the use of
glucose-oxidase reagent strips; One Touch
Ultra, Johnson & Johnson®, New Brunswick,
NJ, USA).
2. Penile tissue was obtained through a circular
incision made at the corona with subsequent
removal of the foreskin and shaft skin and
amputation of the penis at the most extreme
proximal position possible.
Excess blood was removed by gently blotting the
penis on sterile cotton gauze. The underlying
cavernosal tissue was bisected longitudinally into
two right and left halves. The right part was kept at
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−20°C until homogenization in phosphate buffer
saline; subsequently, this tissue was used for deter-
mination of CGRP using the Calcitonin Gene
Related Peptide (CGRP (Rat, Mouse)) EIA kit
(Phoenix Pharmaceuticals, Burlingame, CA, USA)
according to manufacturer instructions [14].
The left half of the peeled penile tissue was
harvested and immersed in neutral buffered
formalin containing 4% formaldehyde for a
period of 6 hours. Specimens were subsequently
embedded in parafﬁn and sectioned at 5 μm using
a rotor microtome. Sections were stained using
hematoxilin and eosin stain for further evaluation
under light microscope. Endothelial disease was
graded on a four-point scale as (i) normal
(no changes); (ii) only ﬂattened endothelium;
(iii) ﬂattened with degree of loss in some areas of
the lining, i.e., (partial loss); and (iv) total loss of
endothelial lining.
After the end of the experiment, animals were
killed by exsanguinations.
Results
The FBG level in the diabetic rats (group IIa,
IIb, IIc, and IId) was signiﬁcantly higher than
group I rats (P < 0.001). The mean FBG in group
I healthy rats was 74.50 ± 5.84 mg/dL. In group
II, the mean fasting blood glucose (FBS) was
405.30 ± 41.43 mg/dL in group IIa, 402.30 ±
25.94 mg/dL in group IIb, 423.0 ± 42.96 mg/dL
in group IIc, and 449.60 ± 35.08 mg/dL in group
IId. Signiﬁcant increase in the FBG level was
noted in group IIb, IIc, and IId in relation to group
IIa rats (P < 0.001).
The mean level of CGRP in penile tissue in
healthy rats was 0.0104 ± 0.0007 ng/mL. In group
II diabetic rats, the mean level of CGRP was
0.0105 ± 0.0005 ng/mL in group IIa, 0.0250 ±
0.0123 ng/mL in group IIb, 8.59321 ±
13.1155 ng/mL in group IIc, and 13.2252 ±
16.6675 ng/mL in group IId (Figure 1A, B). It was
signiﬁcantly higher in the diabetic rats of group IIb
(P1 = 0.002), group IIc (P1 < 0.001), and group IId
(P1 < 0.001) compared with group I (control) as
well as group IIa rats (P2 = 0.012, P2 < 0.001,
P2 < 0.001, respectively).
The level of CGRP increased signiﬁcantly 4
weeks after induction of DM, kept increasing at
6 weeks and at 8 weeks of induction of DM. No
statistically signiﬁcant changes in the level of
CGRP were noted between group IIc (6 weeks
diabetic) and group IId (8 weeks diabetic)
(P4 = 0.940).
Histopathological Changes in Endothelium, Smooth
Muscles, and Vessel Wall Thickness of Corpora
Cavernosa of Rats’ Penises (Table 1)
The left halves of the 50 rats (control group and
four diabetic groups) were blindly examined by
the pathology professor (without respect of being
control or diabetic group). The sections were
examined by light microscopy by both low power
(magniﬁcation ×20) and high power (magniﬁca-
tion ×40).
In group IIa (2 weeks after induction of DM),
signiﬁcant ﬂattening of endothelial lining and
decreased smooth muscle mass occurred in 80% of
rats in relation to the control group (Figure 2A, B).
In group IIb (4 weeks after induction of DM),
ﬂattening with partial loss of the endothelial lining
and decreased muscle mass was reported in 80% of
rats, whereas partial ﬁbrosis of the smooth muscles
was seen in 20% of rats. The vessel wall thickness
started to be decreased (Figure 3A, B). These
changes were statistically signiﬁcant in relation to
the other groups.
In group IIc (6 weeks after induction of DM),
signiﬁcant changes were noted in relation to the
nondiabetic group such as endothelial lining was
ﬂattened and associated with partial loss in 70%
of cases, whereas 30% of rats showed total
endothelial loss. Smooth muscles were partially
ﬁbrosed in 80% of rats and showed complete
hyalinization in 20% of rats. The vessel wall thick-
ness was still decreased.
In group IId (8 weeks after induction of
DM), endothelial lining was totally lost in 80%
of cases and ﬂattened with partial loss in only
20%. Furthermore, 70% of rats showed totally
hyalinized smooth muscles and only 30%
appeared partially ﬁbrosed. Vessel wall thickness
was still decreased (Figure 4). It should be noted
that these histopathological changes were not sig-
niﬁcant in relation to group IIc.
Relation Between the Tissue Level of CGRP and the
Histopathological Changes in Diabetic Rat Penises
During the present study, the level of CGRP
showed signiﬁcant progressive increase in a time-
dependent manner and was accompanied with
deterioration of the endothelial conditions in the
ﬁrst 6 weeks of the study. There was a positive
correlation between the level of CGRP between
group IIa and group IIb when the smooth muscles
changes showed ill deﬁned wall and decreased
muscle mass, also between group IIc and group
IIb when partial ﬁbrosis of the smooth muscles
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was noted in 80% of rats (P = 0.010, P = 0.037,
respectively).
Relation Between the FBG and Histopathological
Changes in Each Studied Group
There were signiﬁcant increase in the FBS level
in relation to smooth muscle pathology changes
as follows: ﬁrst between group IIa and group IIb
when smooth muscles showed ill deﬁned wall with
decreased mass (P = 0.034), then changes between
6 weeks diabetic rats (group IIc) and 8 weeks dia-
betic rats (group IId) (P = 0.014) when smooth
muscles showed partial ﬁbrosis in eight rats and
three rats, respectively, and lastly, when complete
hyalinization occurred in the same groups (two
rats in group IIc and seven rats in group IId)
(P = 0.040).
Discussion
In the current study, type I DM was induced in
group II rats by an intraperitonal injection of STZ.
Forty-eight hours later, all rats showed hyper-
glycemia >300 mg/dL. In fact, the rat model has
been chosen to study the early histopathological
changes and changes in the level of CGRP occur-
ring in the penile tissue in case of type I DM for
many reasons.
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Figure 1 (A) The level of CGRP in the
penile tissue of group II diabetic rats
(ng/mL). (B) A bar graph showing the
level of CGRP in the penile tissue of
group II diabetic rats (ng/mL).
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Table 1 Comparison between the cavernosal endothelial changes in the studied groups
Group I
(Control)
Group IIa
(Diabetic 2 W)
Group IIb
(Diabetic 4 W)
Group IIc
(Diabetic 6 W)
Group IId
(Diabetic 8 W)
No % No % No % No % No %
Endothelium
Normal 10 100.0 2 20.0 0 0.0 0 0.0 0 0.0
Flattened 0 0.0 8 80.0 2 20.0 0 0.0 0 0.0
Flattened + partial loss 0 0.0 0 0.0 8 80.0 7 70.0 2 20.0
Total loss 0 0.0 0 0.0 0 0.0 3 30.0 8 80.0
MCp <0.001*
p1 FEp = 0.001* MCp < 0.001* MCp < 0.001* MCp < 0.001*
p2 MCp = 0.001* MCp < 0.001* MCp < 0.001*
p3 MCp = 0.109 MCp = 0.001*
p4 FEp = 0.070
*Statistically significant at P ≤ 0.05.
MCp = P value for Monte Carlo test; FEp = P value for Fisher’s exact test; p1 = P value between Control with each other weeks; p2 = P value between 2 W with
each other weeks; p3 = P value between 4 W with 6 and 8 weeks; p4 = P value between 6 W and 8 W.
A
B
Figure 2 (A) Normal vascular spaces in corpus cavernosum
of healthy (control) rats. (B) Flattened endothelial lining in
group IIa rats.
A
B
Figure 3 (A) Flattened endothelium with partial loss with
decreased smooth muscle mass in group IIb. (B) Flattened
endothelial with partial loss in some areas while smooth
muscles more atrophic.
Early Changes in Corporeal CGRP in Diabetic Rats 25
Sex Med 2013;1:21–29© 2013 The Authors. Sexual Medicine published by Wiley Periodicals, Inc.
on behalf of International Society for Sexual Medicine.
The rat model in particular provides the most
valuable and reproducible investigations that sig-
niﬁcantly contributed to male sexual dysfunction
as well as in the development of various treatment
modalities [15]. Furthermore, diabetic rats start
to develop dysfunctional erectile responses after 6
weeks of induction of diabetes contrarily to half of
diabetic men who usually suffer from ED within
10 years of diagnosis of DM [16,17].
With regard to the changes in the FBG level in
group II rats (diabetic), it ranged between 350 and
500 mg/dL with progressive signiﬁcant increase
along the ﬁrst 4 weeks of the present study, with no
further signiﬁcant elevations during the remaining
4 weeks of the study. This may be explained by
the progressive damage of beta cells of islets of
Langerhans by STZ due to necrosis and apoptosis
up to a point where no signiﬁcant further damage
could occur. This is consistent with the ﬁndings of
other studies that proved the destructive capacity
of STZ to the pancreas [18].
CGRP is one of the most potent vasodilators in
the body and is postulated to play a role in penile
erection. It is found in large amounts in axons
innervating the penis of rats, dogs, monkeys, and
humans [19,20].
CGRP was chosen in the present work as a
marker to evaluate the effect of type I DM on
unmyelinated sensory nerve endings in the corpus
cavernosum. In the current study, the level of
CGRP started to increase signiﬁcantly in the dia-
betic rats 4 weeks after induction of DM compared
with normal rats and kept on increasing 6 weeks
after induction of DM. The previous results may
reﬂect neuroplastic adjustments in the afferent
innervations in order to compensate for early
diabetes-induced neuropathic changes that may
cause erectile disturbances.
In fact, neurotrophins such as NGF, brain-
derived neurotrophic factor, and NT-3 are
upregulated in the cavernous tissue of diabetic rats
with ED [21]. They play an important role in the
repair and regeneration of injured nerves as well
as regulating the development and function of
postganglionic sympathetic and sensory neurons
[22].
NGF in particular has an important role in the
growth and maintenance of function of sensory
nerves [23]. At a cellular level, NGF upregulates
CGRP via a cAMP/ras responsive element [6],
and via a constitutively active mitogen-activated
protein kinase. In some experiments, the upregu-
lation of CGRP was associated with nerves sprout-
ing, an indication of NGF activity [24]. That is
why the increased CGRP level in the current study
might result from compensatory increase in the
neurotrophin NGF.
The results of the present study are consistent
with another study byMorrison et al., who found a
signiﬁcant elevation of CGRP in the rats corpora
cavernosa after 12 and 16 weeks of induction of
type I DM, though they did not report the early
steady changes in the level of CGRP as in the
current study [12].
Further studies elucidated the possible protec-
tive role of CGRP. It is involved in the mediation
of ischemic preconditioning in the heart, heat
stress reaction, drug-induced preconditioning, and
in endothelial protection [25].
In the present work, in contrast to the expected,
no further signiﬁcant increase in the level of
CGRP occurred in the 8th week of DM compared
to the 6th week. Other investigators even found
that diabetes caused a decrease rather than an
increase in CGRP content [26].
The cause of discontinued increase or even
decrease in the level of CGRP along the diabetes
period is subject to controversies. Some evidence
suggests that chronic hyperglycemia may contrib-
ute to decreased expression of the neuronal genes
that are responsible for NGF formation in diabe-
tes [27–29]. This explanation is supported by the
ﬁndings of many researchers. Tomlinson DR and
his coworkers reported a decreased retrograde
axonal transport of NGF and decreased support of
NGF-dependent sensory neurons, with reduced
expression of their neuropeptides, substance P
and CGRP in diabetics. As expected, correction of
hyperglycemia with intensive insulin therapy nor-
malized these deﬁcits [30].
Figure 4 Atrophic hyalinized smooth muscles with loss of
endothelial lining in group IId.
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Unfortunately, studies found that the increased
level of neurotrophins could not completely
compensate for the severe neuropathy. Similarly,
the endogenous increase in CGRP level may be
neither enough quantitatively nor sustained long
enough to compensate for the nerve dysfunction
[21,31,32].
Yorek et al. reported that, after 10–12 weeks
of induction of type I DM by STZ, there was a
decrease in the CGRP content in epineurial arteri-
oles and the ability of exogenous CGRP to induce
vasodilation. These results may be due to measure-
ment of CGRP level after a longer duration of
diabetes (10–12 weeks) than the duration of the
present study (8weeks), but it alsomay indicate that
the steady changes in CGRP level in the last 2
weeks of the present study could further decrease
with longer duration of hyperglycemia [33].
In the present study, assessment of the diabetic
penile tissue revealed progressive pathological
changes in the endothelium, smooth muscles, and
vessel wall thickness. They were found to coincide
with the duration of diabetes. In fact, 2 weeks after
induction of type I DM, endothelial ﬂattening
occurred in 80% of rats, whereas at 4 weeks, 80%
of rats had ﬂattened endothelium with partial loss,
and at 8 weeks, the endothelium was completely
lost in 80% of rats.
With regard to the smooth muscle changes,
the smooth muscle mass decreased starting from
the 2nd week after induction of type I DM, pro-
gressed to partial replacement by ﬁbrous tissue at
6 weeks and showed complete hyalinization in
70% of rats at 8 weeks. The vessel wall thickness
of the affected vasculature also decreased in
100% of rats starting from the 4th week after
induction of DM.
These results coincide with other studies that
reported that diabetic rabbit penises showed a
signiﬁcant decrease in corporeal vascular volume,
trabecular smooth muscles, cavernous artery
diameter, and luminal volume compared with
controls [34,35].
What Is the Premium Cause of ED:
Neuropathy or Vasculopathy?
A further point of importance should be noted in
the present study: signiﬁcant pathological changes
in the endothelium and smooth muscle started in
the 2nd week (group IIa) in relation to the control
group, whereas the changes of CGRP level started
to be signiﬁcant from the 4th week (group IIb).
These results suggest that vascular changes occur
earlier than neurological abnormalities, and they
may even play a role in the pathogenesis of neu-
rological ED.
Obrosova et al. suggested that diabetes-induced
decrease in nerve blood ﬂow, and resultant
endoneural hypoxia plays a key role in functional
and morphological changes in the diabetic nerve
[36]. Diabetes was also found to induce impair-
ment of endothelium-dependent vascular relax-
ation in vasa nervosum as well as coronary and
mesentery arteries [37].
All these changes could be mostly attributed to
the metabolic derangements caused by diabetes
such as: ﬁrst formation of advanced glycation
end products in rat and human diabetic corpus
cavernosal tissue that bind with vascular collagen
and cause vascular thickening, endothelial dys-
function, and atherosclerosis [16].
Second, generation of reactive oxygen species
[36]. Third, formation of peroxynitrite, oxidiz-
ing agent that rapidly reacts with nitric oxide (NO)
that accumulates in vascular beds thus creating
NO consumption [38] In addition, peroxynitrite
decrease endoneurial nutritive blood ﬂow and vas-
cular reactivity of epineurial arterioles [39].
All these studies support the suggestion for the
primary vascular concept for diabetic ED.
Fourth, diabetesmay interferewith the synthesis
and/or release of NO from both nerves and
endothelium in the corpus cavernosum and that
alterations of endothelium-derived responses
occur earlier than neurological disturbances. These
ﬁndings further support the results of the current
study [40].
In the ﬁrst 6 weeks of the study, smooth muscle
cell changes ran signiﬁcantly parallel to elevated
CGRP level. It should be noted that vascular
smooth muscle cells in the intact vascular wall
are differentiated for contraction. However, the
response to vascular injury involves transition
toward a synthetic phenotype, with increased ten-
dency for proliferation [41]. Exogenous CGRP
can transform the phenotype of corpus cavernosal
smooth muscles in diabetic ED rats from synthetic
to contractile type [32].
In the present study, although up until the 8th
week of the study, the changes in FBS level had
no signiﬁcant relation to the deterioration in
endothelial lining or the changes in the vessel wall
thickness, the FBS level had signiﬁcant relation
to smooth muscles changes between 6th and 8th
week of DM.
It was also found that under hyperglycemic
conditions, the phenotype of corpus cavernosum
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smooth muscles cell change and exhibit less con-
tractility. This could have a key role in the patho-
genesis of diabetic ED [42].
These results support the ﬁndings of the
current work in which decreased smooth muscle
component was correlated with high FBS level,
which has an impact on the erectile function.
It should be noted that the current study had
some limitations. First, the small sample size;
which was mostly due to death of rats with
untreated uncontrolled diabetes. Second, the rela-
tively short duration of the study. However, our
main aim was to assess the early changes in CGRP
in corporeal tissues in diabetes. Third, the lack of
immunohistochemical staining of corporeal tissues
that would further elucidate the sequential patho-
logical changes. This staining is recommended to
be done in further studies.
To summarize, DM is characterized by progres-
sive loss of normal endothelium and smoothmuscle
cells from the corpus cavernosum [43]. The upre-
gulation of the transforming growth factor β-1
(TGF-β1)/Smad/connective tissue growth factor
(CTGF) signaling pathway might play an impor-
tant role in diabetes-induced ﬁbromuscular
changes that ﬁnally ends by deterioration of erectile
function [44].
Our study support the hypothesis that vascu-
lopathy is the primary pathology in diabetic ED as
it occurs earlier than neuropathy and may affect
vasa nervosa. Furthermore, neuropathy may per-
petuate vasculopathy as increased level of CGRP is
associated with changes in smooth muscle type.
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